Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (RDCRN# 6203, Protocol Version Date 07Jan10)

NCT01158807 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT01158807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (RDCRN# 6203, Protocol Version Date 07Jan10)
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Completed
Start date
April 8, 2010
Completion date
June 30, 2025
Enrollment
2,272 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary hemorrhagic telangiectasia